Abiraterone acetate in metastatic castration-resistant prostate cancer – the unanticipated real-world clinical experience

por Poon, Darren M. C., Chan, Kuen, Lee, S. H., Chan, T. W., Sze, Henry, Lee, Eric K. C., Lam, Daisy, Chan, Michelle F. T.
Publicado 2016

Differences in clinical outcome between docetaxel and abiraterone acetate as the first-line treatment in chemo-naïve metastatic castration-resistant prostate cancer patients with o...

por Poon, Darren M.C., Chan, Kuen, Lee, Siu H., Chan, Tim W., Sze, Henry, Lee, Eric K.C., Lam, Daisy, Chan, Michelle F.T.
Publicado 2018